|
[1] MERLINI G,BELLOTTI V.Molecular mechanisms of amyloidosis[J].N Engl J Med,2003,349(6):583-596.
|
|
[2]ZHAO XY,JIA JD,WANG BE,et al.Clinical features of 30 cases of amyloidosis[J].Chin J Hepatol,2005,13(1):42-44.(in Chinese)赵新颜,贾继东,王宝恩,等.30例淀粉样变性患者的临床特点分析[J].中华肝脏病杂志,2005,13(1):42-44.
|
|
[3]SIPE JD,BENSON MD,BUXBAUM JN,et al.Amyloid fibril protein nomenclature:2012 recommendations from the nomenclature committee of the international society of amyloidosis[J].Amyloid,2012,19(4):167-170.
|
|
[4]PALLADINI G,MERLINI G.Systemic amyloidoses:what an internist should know[J].Eur J interm Med,2013,24(8):729-739.
|
|
[5] PARK M,MUELLER P,KYLE R,et al.Primary(AL)hepatic amyloidosis:clinical features and natural history in 98 patients[J].Medicine(Baltimore),2003,82(5):291-298.
|
|
[6] CLOUGH J,SHAH R.Primary amyloidosis presenting as common bile duct obstruction with cholangitis[J].ACG Case Rep J,2015,2(2):107-109.
|
|
[7] LOIZOS S,CHRYSA TS,CHRISTOS GS.Amyloidosis:review and imaging findings[J].Semin Ultrasound CT,2014,35(3):225-239.
|
|
[8]LAVATELLI F,ALBERTINI R,DI FONZO A,et al.Biochemical markers in early diagnosis and management of systemic amyloidoses[J].Clin Chem Lab Med,2014,52(11):1517-1531.
|
|
[9] GIRNIUS S,SELDIN DC,SKINNER M,et al.Hepatic sponse after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease[J].Haematologica,2009,94(7):1029-1032.
|
|
[10]HU YL,PAN Y,XIN GJ,et al.Clinical diagnosis of patients with hepatic amyloid degeneration[J].J Clin Hepatol,2010,26(1):65-66.(in Chinese)胡玉琳,潘煜,辛桂杰,等.4例肝淀粉样变性的临床特点和分析[J].临床肝胆病杂志,2010,26(1):65-66.
|
DownLoad: